Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rassool

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Translational Oncology|November 22, 2021
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancersAnna J Dellomo, Rachel Abbotts, Christian L Eberly, et al.
Molecular Cancer Research : MCR|August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Archives of Psychiatric Nursing|May 23, 2018
Knowledge and Perceptions of Undergraduate Nurses towards the Use of Cocaine (Smoked) in a Brazilian ContextSérgia Cristina Cavalcante Pereira, Luciana Marques Andreto, Ariani Impieri Souza, et al.
Journal of Religion and Health|July 28, 2017
The Factor Structure of the Spiritual Well-Being Scale in Veterans Experienced Chemical Weapon ExposureHamid Sharif Nia, Saeed Pahlevan Sharif, Christopher Boyle, et al.
Oncotarget|July 5, 2016
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stressKshama A Doshi, Rossana Trotta, Karthika Natarajan, et al.
Leukemia Research|April 12, 2016
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatinCarine Robert, Pratik K Nagaria, Nisha Pawar, et al.
Genes, Chromosomes & Cancer|April 29, 1998
An FHIT tumor suppressor gene?M M Le Beau, H Drabkin, T W Glover, et al.
Human Molecular Genetics|May 16, 1998
Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site inductionM M Le Beau, F V Rassool, M E Neilly, et al.
Journal of Synchrotron Radiation|April 20, 2012
Improved count rate corrections for highest data quality with PILATUS detectorsP Trueb, B A Sobott, R Schnyder, et al.
Blood|November 1, 1988
Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemiaC M Price, F Rassool, M K Shivji, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Translational Oncology|November 22, 2021
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancersAnna J Dellomo, Rachel Abbotts, Christian L Eberly, et al.
Molecular Cancer Research : MCR|August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Archives of Psychiatric Nursing|May 23, 2018
Knowledge and Perceptions of Undergraduate Nurses towards the Use of Cocaine (Smoked) in a Brazilian ContextSérgia Cristina Cavalcante Pereira, Luciana Marques Andreto, Ariani Impieri Souza, et al.
Journal of Religion and Health|July 28, 2017
The Factor Structure of the Spiritual Well-Being Scale in Veterans Experienced Chemical Weapon ExposureHamid Sharif Nia, Saeed Pahlevan Sharif, Christopher Boyle, et al.
Oncotarget|July 5, 2016
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stressKshama A Doshi, Rossana Trotta, Karthika Natarajan, et al.
Leukemia Research|April 12, 2016
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatinCarine Robert, Pratik K Nagaria, Nisha Pawar, et al.
Genes, Chromosomes & Cancer|April 29, 1998
An FHIT tumor suppressor gene?M M Le Beau, H Drabkin, T W Glover, et al.
Human Molecular Genetics|May 16, 1998
Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site inductionM M Le Beau, F V Rassool, M E Neilly, et al.
Journal of Synchrotron Radiation|April 20, 2012
Improved count rate corrections for highest data quality with PILATUS detectorsP Trueb, B A Sobott, R Schnyder, et al.
Blood|November 1, 1988
Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemiaC M Price, F Rassool, M K Shivji, et al.
Pageof 23